Abstract
The emergence of dementia during the treatment of schizophrenia is a problem that occurs in many patients. Despite the appearance of strong cautionary language on the product labels of antipsychotic drugs, advising clinicians to avoid the use of these medications in the setting of dementia, there is no specific guidance for the management of dementia in schizophrenia. Here, we report the case of successful antipsychotic drug reduction in a 63-year-old male with paranoia and severely impaired cognition. We explain possible explanations and the implications of this result.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
